Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3645721)

Published in Int J Mol Sci on April 11, 2013

Authors

Xin Li1, Yongping Su, Jinhong Pan, Zhansong Zhou, Bo Song, Enqing Xiong, Zhiwen Chen

Author Affiliations

1: Urologic Institute of PLA, Southwest Hospital, Third Military Medical University, Chongqing 400038, China. yongpingsucq@163.com.

Articles cited by this

Chromatin modifications and their function. Cell (2007) 55.98

The complex language of chromatin regulation during transcription. Nature (2007) 16.97

Global cancer statistics. CA Cancer J Clin (1999) 8.82

Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol (2007) 6.13

Connexins, connexons, and intercellular communication. Annu Rev Biochem (1996) 4.51

Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature (2007) 4.49

JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci U S A (2007) 2.45

Cell-cell communication in carcinogenesis. Front Biosci (1998) 1.79

Diversity within the JMJD2 histone demethylase family. Biochem Biophys Res Commun (2006) 1.74

Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer (2010) 1.64

The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation. Genes Dev (2012) 1.43

Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis. J Biol Chem (2009) 1.38

PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int J Oncol (2011) 1.31

The vertebrate connexin family. Cell Mol Life Sci (2006) 1.20

Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis (2008) 1.12

KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet (2011) 1.10

IL-8 as a urinary biomarker for the detection of bladder cancer. BMC Urol (2012) 1.09

Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res (2008) 1.08

Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Biochem Biophys Res Commun (2011) 1.06

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer. BMC Cancer (2011) 1.03

Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. FEBS J (2012) 1.00

Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am J Transl Res (2012) 0.98

Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol (1998) 0.97

Decreased connexin expression and intercellular communication in human bladder cancer cells. Cancer Res (1994) 0.95

Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin. Hum Gene Ther (2001) 0.95

Cancer, apoptosis, and nonimmune surveillance. Cell Death Differ (2004) 0.94

The histone H3K36 demethylase Rph1/KDM4 regulates the expression of the photoreactivation gene PHR1. Nucleic Acids Res (2011) 0.93

The JMJD2 members of histone demethylase revisited. Mol Biol Rep (2007) 0.92

Current concepts in biomarker technology for bladder cancers. Clin Chem (2000) 0.91

Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). J Proteomics (2012) 0.89

Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Int J Oncol (2012) 0.87

Connexin 26 is abnormally expressed in bladder cancer. J Urol (2003) 0.87

Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int J Cancer (2005) 0.86

Decreased expression of connexin-30 and aberrant expression of connexin-26 in human head and neck cancer. Anticancer Res (2007) 0.84

Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen. PLoS One (2012) 0.84

Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. Gene Ther (2001) 0.78

[Clinical problems in patients who were exposed to carcinogens]. Hinyokika Kiyo (1989) 0.77

Articles by these authors

Central nervous system damage due to acute paraquat poisoning: a neuroimaging study with 3.0 T MRI. Neurotoxicology (2012) 3.27

A review of NIR dyes in cancer targeting and imaging. Biomaterials (2011) 2.76

Spatial distribution of soil heavy metal pollution estimated by different interpolation methods: accuracy and uncertainty analysis. Chemosphere (2010) 1.84

4,4',5,5'-Tetra-phenyl-3,3'-[methyl-idene-bis(sulfanedi-yl)]bis-(4H-1,2,4-triazole). Acta Crystallogr Sect E Struct Rep Online (2010) 1.81

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78

A report of 918 cases of circumcision with the Shang Ring: comparison between children and adults. Urology (2013) 1.46

Prognostic significance of miR-215 in colon cancer. Clin Colorectal Cancer (2011) 1.44

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One (2009) 1.40

Specific management of acute renal failure caused by an upper ureteral stone in a solitary pelvic kidney. Urol Res (2010) 1.40

Platelet-derived growth factor-BB increases expression of connexin 43 in an extracellular-regulated protein kinase-dependent manner in bladder smooth muscle cells. Int J Urol (2012) 1.40

Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res (2004) 1.33

Competitive binding of postsynaptic density 95 and Ca2+-calmodulin dependent protein kinase II to N-methyl-D-aspartate receptor subunit 2B in rat brain. Acta Pharmacol Sin (2004) 1.28

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res (2010) 1.26

Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res (2007) 1.23

Normalizing genes for real-time polymerase chain reaction in epithelial and nonepithelial cells of mouse small intestine. Anal Biochem (2009) 1.22

Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res (2006) 1.21

Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet (2013) 1.17

PKA phosphorylation couples hepatic inositol-requiring enzyme 1alpha to glucagon signaling in glucose metabolism. Proc Natl Acad Sci U S A (2011) 1.17

Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett (2009) 1.15

A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Prostate (2012) 1.15

Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol Oncol (2011) 1.14

Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agents. Acad Radiol (2002) 1.10

A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials (2010) 1.09

More insight into mesenchymal stem cells and their effects inside the body. Expert Opin Biol Ther (2010) 1.07

Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discov Today (2008) 1.06

Detection of nanobacteria infection in type III prostatitis. Urology (2008) 1.06

Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets (2012) 1.05

Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res (2007) 1.05

TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells. Int J Biochem Cell Biol (2011) 1.03

Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis. Neurology (2013) 1.02

Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. Prostate (2013) 1.00

The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. J Biol Chem (2008) 1.00

Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol Ther (2012) 0.99

miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol (2012) 0.97

Grey leaves in an alpine plant: a cryptic colouration to avoid attack? New Phytol (2014) 0.97

Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials (2009) 0.96

Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clin Cancer Res (2007) 0.96

A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties. Biomaterials (2011) 0.95

One-step solvothermal synthesis of highly water-soluble, negatively charged superparamagnetic Fe3O4 colloidal nanocrystal clusters. Nanoscale (2013) 0.95

Changes of gap junctional cell-cell communication in overactive detrusor in rats. Am J Physiol Cell Physiol (2007) 0.95

The effects of total-body irradiation on the survival and skin wound healing of rats with combined radiation-wound injury. J Trauma (2004) 0.95

Altered expression of calcium-activated K and Cl channels in detrusor overactivity of rats with partial bladder outlet obstruction. BJU Int (2008) 0.95

Transurethral endoscopy technique with a ureteroscope for diagnosis and management of seminal tracts disorders: a new approach. J Endourol (2008) 0.94

A power-free microfluidic chip for SNP genotyping using graphene oxide and a DNA intercalating dye. Chem Commun (Camb) (2013) 0.93

The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim Biophys Acta (2012) 0.93

Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology (2009) 0.93

Trichodermone, a spiro-cytochalasan with a tetracyclic nucleus (7/5/6/5) skeleton from the plant endophytic fungus Trichoderma gamsii. J Nat Prod (2014) 0.93

MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Brain Res Bull (2012) 0.93

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer. PLoS One (2013) 0.93

Reconstitution of phycobilisome core-membrane linker, LCM, by autocatalytic chromophore binding to ApcE. Biochim Biophys Acta (2005) 0.93

COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. Int J Mol Med (2013) 0.92

Angiosarcoma of the penis: a case report and literature review. Int Urol Nephrol (2012) 0.92

N-methyl-D-aspartate receptor and L-type voltage-gated Ca2+ channel activation mediate proline-rich tyrosine kinase 2 phosphorylation during cerebral ischemia in rats. Neurosci Lett (2004) 0.92

Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Int J Mol Sci (2012) 0.91

Efficacy of endoscopic therapy for gastrointestinal bleeding from Dieulafoy's lesion. World J Gastroenterol (2011) 0.91

Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int J Med Sci (2012) 0.91

Stereotactic localisation system: a modified puncture technique for percutaneous nephrolithotomy. Urol Res (2011) 0.91

Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today (2010) 0.90

Loss of ryanodine receptor calcium-release channel expression associated with overactive urinary bladder smooth muscle contractions in a detrusor instability model. BJU Int (2005) 0.90

Active deformation of apoptotic intestinal epithelial cells with adhesion-restricted polarity contributes to apoptotic clearance. Lab Invest (2010) 0.90

Minimally invasive plating osteosynthesis for mid-distal third humeral shaft fractures. Orthopedics (2013) 0.90

[Spatial distribution patterns and associations of Pinus koraiensis and Tilia amurensis in broad-leaved Korean pine mixed forest in Changbai Mountains]. Ying Yong Sheng Tai Xue Bao (2007) 0.89

Diagnosis of male posterior urethral stricture: comparison of 64-MDCT urethrography vs. standard urethrography. Abdom Imaging (2011) 0.89

Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip). Nucleic Acids Res (2010) 0.89

Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. J Cell Biochem (2011) 0.89

Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases. J Endourol (2008) 0.89

A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma. Biomaterials (2010) 0.89

Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey. Chin Med J (Engl) (2008) 0.89

Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res (2005) 0.89

XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J Urol (2010) 0.88

A multifunctional heptamethine near-infrared dye for cancer theranosis. Biomaterials (2012) 0.88

Nonenzymatic chromophore attachment in biliproteins: conformational control by the detergent Triton X-100. Biochim Biophys Acta (2004) 0.87

Antibacterial activity of the lipopetides produced by Bacillus amyloliquefaciens M1 against multidrug-resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol Biotechnol (2013) 0.87

Changes in T-type calcium channel and its subtypes in overactive detrusor of the rats with partial bladder outflow obstruction. Neurourol Urodyn (2007) 0.87

The effects of the c-kit blocker glivec on the contractile response of urinary bladder. J Surg Res (2011) 0.87

ER stress induced by ionising radiation in IEC-6 cells. Int J Radiat Biol (2010) 0.87

Integration and excision of a newly discovered bacteroides conjugative transposon, CTnBST. J Bacteriol (2006) 0.87

Roles of stem cell factor on loss of interstitial cells of Cajal in bladder of diabetic rats. Urology (2011) 0.87

Progress in research on radiation combined injury in China. Radiat Res (2008) 0.87

Comparing spatio-temporal clusters of arthropod-borne infections using administrative medical claims and state reported surveillance data. Spat Spatiotemporal Epidemiol (2012) 0.87

Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer. PLoS One (2013) 0.86

Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment. Int Urogynecol J (2009) 0.86

A versatile ditopic ligand system for sensitizing the luminescence of bimetallic lanthanide bio-imaging probes. Chemistry (2008) 0.86

Isolation and characterization of two kinds of stem cells from the same human skin back sample with therapeutic potential in spinal cord injury. PLoS One (2012) 0.86

Bioconjugated lanthanide luminescent helicates as multilabels for lab-on-a-chip detection of cancer biomarkers. Analyst (2009) 0.86

On-chip immunoassay using electrostatic assembly of streptavidin-coated bead micropatterns. Anal Chem (2009) 0.86

Stem cells and their applications in skin-cell therapy. Trends Biotechnol (2005) 0.86